Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/20/2019
Closing price: 238.79
|Support price level:||$225.16|
|Resistance price level:||$241.74|
|Relative strength index (14-day RSI)||74.4|
- With a -29.5 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 36.6%.
- Volatility is forecast to fall over the next month.
- With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 9.9% in the next week.
- 20.8% in the next month.
- 79.3% in the next year.